AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation

Inclusion Criteria

• •Participant with clinical diagnosis of acne vulgaris, defined by:
• •1. moderate acne on the face (acne Investigator's Global Assessment \[IGA\] =3); and
• •2. with minimum of 20 inflammatory lesions and 25 non inflammatory lesions on the face (excluding the nose); and
• •3. moderate to marked PIH on the face (Overview of Pigmentation Disorders hyperpigmentation scale 4-6); and
• •4. no more than one acne nodule or cyst (greater than \[\>\] 1 centimeter \[cm\]) on face (excluding the nose)
• •Participant with any Fitzpatrick Skin Type I to VI (target patient enrollment according to FST)
• •Female participants of childbearing potential must have a negative urine pregnancy test (UPT) at Baseline visit
• •Female participants of childbearing potential must agree to use an adequate and approved method of contraception throughout the study
• •Female participant of non-childbearing potential